rAAV1.CMV.huFollistatin344

follistatin-344 gene therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rAAV1.CMV.huFollistatin344, covering 2020-04-15 to 2020-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy [Phase 1, Phase 2]

See pricing